Bullock, Kristin M.

Plasma exosomal α-synuclein is likely CNS-derived and increased in Parkinson’s disease

Shi, M., Liu, C., Cook, T. J., Bullock, K. M., Zhao, Y., Ginghina, C., Li, Y., Aro, P., Dator, R., He, C., et al. (2014) · Acta Neuropathologica

Parkinson's Disease Mechanisms and TreatmentsExtracellular vesicles in disease

Cited by 676

Macrophage exosomes as natural nanocarriers for protein delivery to inflamed brain

Yuan, D., Zhao, Y., Banks, W. A., Bullock, K. M., Haney, M., Batrakova, E., & Kabanov, A. V. (2017) · Biomaterials

Extracellular vesicles in diseaseNanoparticle-Based Drug Delivery

Cited by 607

Transport of Extracellular Vesicles across the Blood-Brain Barrier: Brain Pharmacokinetics and Effects of Inflammation

Banks, W. A., Sharma, P., Bullock, K. M., Hansen, K. M., Ludwig, N., & Whiteside, T. L. (2020) · International Journal of Molecular Sciences

Extracellular vesicles in diseaseBarrier Structure and Function Studies

Cited by 561

Alpha synuclein is transported into and out of the brain by the blood-brain barrier

Sui, Y.-T., Bullock, K. M., Erickson, M. A., Zhang, J., & Banks, W. A. (2014) · Peptides

Parkinson's Disease Mechanisms and TreatmentsBarrier Structure and Function Studies

Cited by 212

CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease

Shi, M., Kovac, A., Korff, A., Cook, T. J., Ginghina, C., Bullock, K. M., Yang, L., Stewart, T., Zheng, D., Aro, P., et al. (2016) · Alzheimer's & Dementia

Alzheimer's disease research and treatmentsExtracellular vesicles in disease

Cited by 206